Literature DB >> 28236259

A Retrospective Cross-Sectional and Longitudinal Study of the Effects of Age on CNS Vital Signs Scores in High-School Athletes.

Sharon D Rogers1, Patrick J Smith2, Alexandra J Stephenson3, D Erik Everhart3.   

Abstract

INTRODUCTION: Current recommendations for concussion management acknowledge the importance of objective assessments of neuropsychological (NP) ability, and computerized NP assessments have been widely integrated into the concussion management protocols of high schools. The optimal intervals for baseline test administration in high-school athletes are currently uncertain. The ability to accurately detect subtle NP deficits is particularly important for high-school athletes, in which concussions are increasingly recognized for adverse effects to the developing brain.
PURPOSE: The aim of this study was to assess the pattern of change in neurocognitive test performance, as well as changes in different domains of NP functioning over time.
METHODS: Baseline computerized NP assessments were conducted at six high schools over 4 academic years using CNS Vital Signs, a battery consisting of seven well-established NP tests. Data were retrospectively examined for age differences in both cross-sectional (n = 3015) and longitudinal (n = 1221) analyses.
RESULTS: Moderate changes were observed across several NP domains over time (Cohen's d = 0.39-0.61), with the largest improvements observed in executive functioning (mean improvement 5.78, 95% confidence interval [CI] 5.41-6.14, p < 0.001), psychomotor speed (mean improvement 4.59, 95% CI 3.97-5.22, p < 0.001), cognitive flexibility (mean improvement 5.11, 95% CI 4.76-5.45, p < 0.001), and reaction time (mean improvement -12.44 ms, 95% CI -10.10 to -14.78, p < 0.001). Improvements in NP performance were most pronounced between the freshman and senior years.
CONCLUSIONS: There is an appreciable change that occurs each year of high school in one or more domains of an NP battery, with executive functioning indicating the greatest magnitude of change. Females performed better relative to males across all time points though males exhibited more substantial improvement over time.

Entities:  

Keywords:  Cognitive Flexibility; Continuous Performance Test; Executive Functioning; Psychomotor Speed; Test Administration

Mesh:

Year:  2017        PMID: 28236259     DOI: 10.1007/s40279-017-0686-2

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  27 in total

1.  Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs.

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  Arch Clin Neuropsychol       Date:  2006-10-02       Impact factor: 2.813

Review 2.  Computerized neurocognitive testing in the management of sport-related concussion: an update.

Authors:  Jacob E Resch; Michael A McCrea; C Munro Cullum
Journal:  Neuropsychol Rev       Date:  2013-12-04       Impact factor: 7.444

3.  Group versus individual administration affects baseline neurocognitive test performance.

Authors:  Rosemarie Scolaro Moser; Philip Schatz; Katherine Neidzwski; Summer D Ott
Journal:  Am J Sports Med       Date:  2011-08-09       Impact factor: 6.202

4.  One-year test-retest reliability of the online version of ImPACT in high school athletes.

Authors:  R J Elbin; Philip Schatz; Tracey Covassin
Journal:  Am J Sports Med       Date:  2011-08-12       Impact factor: 6.202

5.  Consensus statement on concussion in sport--the 4th International Conference on Concussion in Sport held in Zurich, November 2012.

Authors:  Paul McCrory; Willem Meeuwisse; Mark Aubry; Bob Cantu; Jiri Dvorak; Ruben J Echemendia; Lars Engebretsen; Karen Johnston; Jeffrey S Kutcher; Martin Raftery; Allen Sills; Brian W Benson; Gavin A Davis; Richard G Ellenbogen; Kevin M Guskiewicz; Stanley A Herring; Grant Iverson; Barry D Jordan; James Kissick; Michael McCrea; Andrew S McIntosh; David L Maddocks; Michael Makdissi; Laura Purcell; Margot Putukian; Michael Turner; Kathryn Schneider; Charles H Tator
Journal:  Clin J Sport Med       Date:  2013-03       Impact factor: 3.638

6.  National High School Athlete Concussion Rates From 2005-2006 to 2011-2012.

Authors:  Joseph A Rosenthal; Randi E Foraker; Christy L Collins; R Dawn Comstock
Journal:  Am J Sports Med       Date:  2014-04-16       Impact factor: 6.202

Review 7.  Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.

Authors:  James Swanson; Ruben D Baler; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

8.  Executive functioning shows differential maturation from early to late adolescence: longitudinal findings from a TRAILS study.

Authors:  Sarai R Boelema; Zeena Harakeh; Johan Ormel; Catharina A Hartman; Wilma A M Vollebergh; Martine J E van Zandvoort
Journal:  Neuropsychology       Date:  2013-12-23       Impact factor: 3.295

9.  Age and test setting affect the prevalence of invalid baseline scores on neurocognitive tests.

Authors:  Jonathan D Lichtenstein; Rosemarie Scolaro Moser; Philip Schatz
Journal:  Am J Sports Med       Date:  2013-11-15       Impact factor: 6.202

Review 10.  American Medical Society for Sports Medicine position statement: concussion in sport.

Authors:  Kimberly G Harmon; Jonathan A Drezner; Matthew Gammons; Kevin M Guskiewicz; Mark Halstead; Stanley A Herring; Jeffrey S Kutcher; Andrea Pana; Margot Putukian; William O Roberts
Journal:  Br J Sports Med       Date:  2013-01       Impact factor: 13.800

View more
  1 in total

1.  Monitoring the health of transitioning professional footballers: protocol of an observational prospective cohort study.

Authors:  Vincent Gouttebarge; Thor Einar Andersen; Charlotte Cowie; Edwin Goedhart; Harald Jorstad; Simon Kemp; Marsh Königs; Mario Maas; Emmanuel Orhant; Jussi Rantanen; Jari Salo; Luis Serratosa; Keith Stokes; Johannes L Tol; Evert Verhagen; Alexis Weber; Gino Kerkhoffs
Journal:  BMJ Open Sport Exerc Med       Date:  2019-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.